129 related articles for article (PubMed ID: 10442581)
1. The use of self-rating questionnaires as a quantitative measure of quality of life in adult growth hormone deficiency.
Murray RD; Shalet SM
J Endocrinol Invest; 1999; 22(5 Suppl):118-26. PubMed ID: 10442581
[TBL] [Abstract][Full Text] [Related]
2. The influence of growth hormone (GH) deficiency and GH replacement on quality of life in GH-deficient patients.
Deijen JB; van der Veen EA
J Endocrinol Invest; 1999; 22(5 Suppl):127-36. PubMed ID: 10442582
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
[TBL] [Abstract][Full Text] [Related]
4. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
[TBL] [Abstract][Full Text] [Related]
5. Measurements of quality of life in patients with growth hormone deficiency.
Webb SM
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):52-5. PubMed ID: 19020387
[TBL] [Abstract][Full Text] [Related]
6. Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption.
Svensson J; Mattsson A; Rosén T; Wirén L; Johannsson G; Bengtsson BA; Koltowska Häggström M;
Growth Horm IGF Res; 2004 Jun; 14(3):207-15. PubMed ID: 15125882
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in congenital, untreated, lifetime isolated growth hormone deficiency.
Barbosa JA; Salvatori R; Oliveira CR; Pereira RM; Farias CT; Britto AV; Farias NT; Blackford A; Aguiar-Oliveira MH
Psychoneuroendocrinology; 2009 Jul; 34(6):894-900. PubMed ID: 19181452
[TBL] [Abstract][Full Text] [Related]
8. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
[TBL] [Abstract][Full Text] [Related]
9. Sleep apnoea and quality of life in growth hormone (GH)-deficient adults before and after 6 months of GH replacement therapy.
Peker Y; Svensson J; Hedner J; Grote L; Johannsson G
Clin Endocrinol (Oxf); 2006 Jul; 65(1):98-105. PubMed ID: 16817827
[TBL] [Abstract][Full Text] [Related]
10. The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism.
Oertel H; Schneider HJ; Stalla GK; Holsboer F; Zihl J
Psychoneuroendocrinology; 2004 Aug; 29(7):839-50. PubMed ID: 15177699
[TBL] [Abstract][Full Text] [Related]
11. Differential effect sizes of growth hormone replacement on Quality of Life, well-being and health status in growth hormone deficient patients: a meta-analysis.
Deijen JB; Arwert LI; Witlox J; Drent ML
Health Qual Life Outcomes; 2005 Oct; 3():63. PubMed ID: 16236167
[TBL] [Abstract][Full Text] [Related]
12. Is the somatopause an indication for growth hormone replacement?
Savine R; Sönksen PH
J Endocrinol Invest; 1999; 22(5 Suppl):142-9. PubMed ID: 10442584
[TBL] [Abstract][Full Text] [Related]
13. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in growth hormone deficiency and acromegaly.
Webb SM; Badia X
Endocrinol Metab Clin North Am; 2007 Mar; 36(1):221-32. PubMed ID: 17336742
[TBL] [Abstract][Full Text] [Related]
15. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome.
Höybye C; Thorén M; Böhm B
J Intellect Disabil Res; 2005 Apr; 49(Pt 4):245-52. PubMed ID: 15816811
[TBL] [Abstract][Full Text] [Related]
16. Validation of the Japanese version of the Quality of Life-Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA).
Suzukamo Y; Noguchi H; Takahashi N; Shimatsu A; Chihara K; Green J; Fukuhara S
Growth Horm IGF Res; 2006; 16(5-6):340-7. PubMed ID: 17081792
[TBL] [Abstract][Full Text] [Related]
17. [Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].
Reine G; Lancon C; Simeoni MC; Duplan S; Auquier P
Encephale; 2003; 29(2):137-47. PubMed ID: 14567165
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.
Svensson J; Finer N; Bouloux P; Bevan J; Jonsson B; Mattsson AF; Lundberg M; Harris PE; Koltowska-Häggström M; Monson JP;
Growth Horm IGF Res; 2007 Feb; 17(1):67-76. PubMed ID: 17223598
[TBL] [Abstract][Full Text] [Related]
19. Safety aspects of pharmacological GH therapy in adults.
Carroll PV; Van den Berghe G
Growth Horm IGF Res; 2001 Jun; 11(3):166-72. PubMed ID: 11735231
[TBL] [Abstract][Full Text] [Related]
20. Quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA): comparison of normative reference data for the general population of England and Wales with results for adult hypopituitary patients with growth hormone deficiency.
Kołtowska-Haggstrom M; Hennessy S; Mattsson AF; Monson JP; Kind P
Horm Res; 2005; 64(1):46-54. PubMed ID: 16103683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
